Spiro[1,5,6,7-tetrahydroimidazo[4,5-c]pyridine-4,1'-cyclohexane] is a bicyclic compound characterized by its unique spiro structure, which consists of a fused imidazo-pyridine ring and a cyclohexane moiety. This compound features a nitrogen-containing heterocyclic framework, contributing to its potential biological activity. The presence of multiple rings and nitrogen atoms can influence its chemical reactivity, solubility, and interaction with biological targets. Typically, such compounds may exhibit interesting pharmacological properties, making them of interest in medicinal chemistry. The spiro configuration often leads to unique stereochemical properties, which can affect the compound's binding affinity and selectivity for various receptors or enzymes. Additionally, the tetrahydro form indicates that the compound is saturated, which may enhance its stability compared to unsaturated analogs. Overall, spiro[1,5,6,7-tetrahydroimidazo[4,5-c]pyridine-4,1'-cyclohexane] represents a class of compounds that could be explored for their potential therapeutic applications, although specific biological activities would require further investigation.

spiro[1,5,6,7-tetrahydroimidazo[4,5-c]pyridine-4,1'-cyclohexane]

18096-45-2: Spiro[1,5,6,7-tetrahydroimidazo[4,5-c]pyridine-4,1'-cyclohexane] is a bicyclic compound characterized by its unique spiro structure, which consists of a fused imidazo-pyridine ring and a cyclohexane moiety. This compound features a nitrogen-containing heterocyclic framework, contributing to its potential biological activity. The presence of multiple rings and nitrogen atoms can influence its chemical reactivity, solubility, and interaction with biological targets. Typically, such compounds may exhibit interesting pharmacological properties, making them of interest in medicinal chemistry. The spiro configuration often leads to unique stereochemical properties, which can affect the compound's binding affinity and selectivity for various receptors or enzymes. Additionally, the tetrahydro form indicates that the compound is saturated, which may enhance its stability compared to unsaturated analogs. Overall, spiro[1,5,6,7-tetrahydroimidazo[4,5-c]pyridine-4,1'-cyclohexane] represents a class of compounds that could be explored for their potential therapeutic applications, although specific biological activities would require further investigation.

CAS 18096-45-2

spiro[1,5,6,7-tetrahydroimidazo[4,5-c]pyridine-4,1'-cyclohexane]

3',5',6',7'-Tetrahydrospiro[cyclohexane-1,4'-imidazo[4,5-c]pyridine]

Ref: IN-DA0022HG

3′,5′,6′,7′-Tetrahydrospiro[cyclohexane-1,4′-imidazo[4,5-c]pyridine]

Ref: 10-F311098